section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefazolin sodium

(Mfr: SKF)(Conc: 20 mg/mLa)

I

Hetastarch in sodium chloride 0.9%

(Mfr: DCC)(Conc: 6%)

Remarks:

Simulation in vials showed no incompatibility, but white precipitate formed in Y-site during infusion

Ref:

1315